Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis
A.-K. Daum, L. Schlicker, M. A. Schneider, T. Muley, U. Klingmüller, A. Schulze, M. Thomas, P. Christopoulos, H. Sültmann
This study shows cancer-associated fibroblasts enhance drug resistance in ALK-driven lung adenocarcinoma by promoting lipid biosynthesis and suppressing lipid peroxidation through AKT signaling.
bioRxiv · Aug 8, 2023 · PreprintCancer Biology